Toward an understanding of NKT cell biology: Progress and paradoxes

Annual Review of Immunology

Volumn 23, Issue , 2005, Pages 877-900

  Kronenberg, Mitchell ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

CD1d; Glycolipid; Natural killer; T cell

Indexed keywords

CD1D ANTIGEN; GLYCOLIPID; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN;

CELL SELECTION; CELL SPECIFICITY; CELL STIMULATION; CELL SURVIVAL; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; IMMUNOTHERAPY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL MOVEMENT; CYTOKINES; GALACTOSYLCERAMIDES; HOMEOSTASIS; HUMANS; KILLER CELLS, NATURAL; MODELS, IMMUNOLOGICAL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTE SUBSETS;

EID: 17144374753     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.23.021704.115742     Document Type: Review

References (153)

1. Kronenberg M, Gapin L. 2002. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2:557-68
2. Smyth MJ, Crowe NY, Hayakawa Y, Takeda K, Yagita H, Godfrey DI. 2002. NKT cells-conductors of tumor immunity? Curr. Opin. Immunol. 14:165-71
3. Hammond KJ, Kronenberg M. 2003. Natural killer T cells: natural or unnatural regulators of autoimmunity? Curr. Opin. Immunol. 15:683-89
4. Skold M, Behac SM. 2003. Role of CD1d-restricted NKT cells in microbial immunity. Infect. Immun. 71:5447-55
5. Taniguchi M, Harada M, Kojo S, Nakayama T, Wakao H. 2003. The regulatory role of Vα14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21:483-513
6. Brigl M, Brenner MB. 2004. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22:817-90
7. Matsuda JL, Naidenko OV, Gapin L, Nakayama T, Taniguchi M, et al. 2000. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192:741-54
8. pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179:1285-95
9. Bendelac A, Rivera MN, Park SH, Roark JH. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535-62
10. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L. 2004. NKT cells: What's in a name? Nat. Rev. Immunol. 4:231-37
11. + T cells. J. Immunol. 164:2009-15
12. - α/β cells demonstrates preferential use of several Vβ genes and an invariant TCRα chain. J. Exp. Med. 178:1-16
13. - T cells. J. Exp. Med. 180:1171-76
14. Brossay L, Chioda M, Burdin N, Koezuka Y, Casorati G, et al. 1998. CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188:1521-28
15. Spada FM, Koezuka Y, Porcelli SA. 1998. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J. Exp. Med. 188:1529-34
16. Benlagha K, Weiss A, Beavis A, Teyton L, Bendelac A. 2000. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191:1895-903
17. Karadimitris A, Gadola S, Altamirano M, Brown D, Woolfson A, et al. 2001. Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proc. Natl. Acad. Sci. USA 98:3294-98
18. Kita H, Naidenko OV, Kronenberg M, Ansari AA, Rogers P, et al. 2002. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology 123:1031-43
19. Lee PT, Putnam A, Benlagha K, Teyton L, Gottlieb PA, Bendelac A. 2002. Testing the NKT cell hypothesis of human IDDM pathogenesis. J. Clin. Invest. 110:793-800
20. + NKT cells by repeated stimulation with KRN7000. J. Immunol. Methods 285:197-214
21. Gapin L, Matsuda JL, Surh CD, Kronenberg M. 2001. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat. Immunol. 2:971-78
22. Benlagha K, Kyin T, Beavis A, Teyton L, Bendelac A. 2002. A thymic precursor to the NK T cell lineage. Science 296:553-55
23. + CD1d-dependent precursor stage. J. Exp. Med. 195:835-44
24. + cells. J. Immunol. 164:2412-18
25. Forestier C, Park SH, Wei D, Benlagha K, Teyton L, Bendelac A. 2003. T cell development in mice expressing CD1d directed by a classical MHC class II promoter. J. Immunol. 171:4096-104
26. Elewaut D, Kronenberg M. 2000. Molecular biology of NK T cell specificity and development. Semin. Immunol. 12:561-68
27. Sivakumar V, Hammond KJ, Howells N, Pfeffer K, Weih F. 2003. Differential requirement for Rel/nuclear factor κB family members in natural killer T cell development. J. Exp. Med. 197:1613-21
28. Stanic AK, Bezbradica JS, Park JJ, Matsuki N, Mora AL, et al. 2004. NF-κB controls cell fate specification, survival, and molecular differentiation of immunoregulatory natural T lymphocytes. J. Immunol. 172:2265-73
29. + regulatory and natural killer-like T cells on signals leading to NF-κB activation. Proc. Natl. Acad. Sci. USA 101:4566-71
30. i NKT cells. J. Exp. Med. 197:1623-33
31. i NKT cells. Immunity 20:477-94
32. i NKT cells. J. Exp. Med. 198:1133-46
33. Cernadas M, Sugita M, van der Wel N, Cao X, Gumperz JE, et al. 2003. Lysosomal localization of murine CD1d mediated by AP-3 is necessary for NK T cell development. J. Immunol. 171:4149-55
34. Zhou D, Cantu C 3rd, Sagiv Y, Schrantz N, Kulkarni AB, et al. 2004. Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins. Science 303:523-27
35. Kang SJ, Cresswell P. 2004. Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells. Nat. Immunol. 5:175-81
36. Stetson DB, Mohrs M, Reinhardt RL, Baron JL, Wang ZE, et al. 2003. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 198:1069-76
37. Gadue P, Stein PL. 2002. NK T cell precursors exhibit differential cytokine regulation and require Itk for efficient maturation. J. Immunol. 169:2397-406
38. Eberl G, Lowin-Kropf B, MacDonald HR. 1999. Cutting edge: NKT cell development is selectively impaired in Fyn-deficient mice. J. Immunol. 163:4091-94
39. Gadue P, Morton N, Stein PL. 1999. The Src family tyrosine kinase Fyn regulates natural killer T cell development. J. Exp. Med. 190:1189-96
40. Gadue P, Yin L, Jain S, Stein PL. 2004. Restoration of NK T cell development in fyn-mutant mice by a TCR reveals a requirement for Fyn during early NK T cell ontogeny. J Immunol. 172:6093-100
41. + T cells. Eur. J. Immunol. 27:1576-79
42. Cheroutre H. 2004. Starting at the beginning: new perspectives on the biology of mucosal T cells. Annu. Rev. Immunol. 22:217-46
43. + T cells are positively selected in the thymus by agonist self-peptides. Immunity 16:355-64
44. Yamagata T, Mathis D, Benoist C. 2004. Self-reactivity in thymic double-positive cells commits cells to a CD8αα lineage with characteristics of innate immune cells. Nat. Immunol. 5:597-605
45. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2:301-6
46. + thymocytes selected by MHC class I molecules. Science 263:1774-78
47. Hernandez-Hoyos G, Sohn SJ, Rothenberg EV, Alberola-Ila J. 2000. Lck activity controls CD4/CD8 T cell lineage commitment. Immunity 12:313-22
48. Singer A. 2002. New perspectives on a developmental dilemma: the kinetic signaling model and the importance of signal duration for the CD4/CD8 lineage decision. Curr. Opin. Immunol. 14:207-15
49. Prussin C, Foster B. 1997. TCR Vα24 and Vβ11 coexpression defines a human NK1 T cell analog containing a unique Th0 subpopulation. J. Immunol. 159:5862-70
50. Gumperz JE, Miyake S, Yamamura T, Brenner MB. 2002. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195:625-36
51. Chun T, Page MJ, Gapin L, Matsuda JL, Xu H, et al. 2003. CD1d-expressing dendritic cells but not thymic epithelial cells can mediate negative selection of NKT cells. J. Exp. Med. 197:907-18
52. Pellicci DG, Uldrich AP, Kyparissoudis K, Crowe NY, Brooks AG, et al. 2003. Intrathymic NKT cell development is blocked by the presence of α-galactosylceramide. Eur. J. Immunol. 33:1816-23
53. Schumann J, Voyle RB, Wei BY, MacDonald HR. 2003. Cutting edge: influence of the TCR Vβ domain on the avidity of CD1d:α-galactosylceramide binding by invariant Vα14 NKT cells. J. Immunol. 170:5815-19
54. Hayakawa Y, Berzins SP, Crowe NY, Godfrey DI, Smyth MJ. 2004. Antigen-induced tolerance by intrathymic modulation of self-recognizing inhibitory receptors. Nat. Immunol. 5:590-96
55. Voyle RB, Beermann F, Lees RK, Schumann J, Zimmer J, et al. 2003. Ligand-dependent inhibition of CD1d-restricted NKT cell development in mice transgenic for the activating receptor Ly49D. J. Exp. Med. 197:919-25
56. Kim CH, Butcher EC, Johnston B. 2002. Distinct subsets of human Vα24-invariant NKT cells: cytokine responses and chemokine receptor expression. Trends Immunol. 23:516-19
57. Johnston B, Kim CH, Soler D, Emoto M, Butcher EC. 2003. Differential chemokine responses and homing patterns of murine TCR αβ NKT cell subsets. J. Immunol. 171:2960-69
58. Thomas SY, Hou R, Boyson JE, Means TK, Hess C, et al. 2003. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J. Immunol. 171:2571-80
59. Lee PT, Benlagha K, Teyton L, Bendelac A. 2002. Distinct functional lineages of human Vα24 natural killer T cells. J. Exp. Med. 195:637-41
60. Nieuwenhuis EE, Matsumoto T, Exley M, Schleipman RA, Glickman J, et al. 2002. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat. Med. 8:588-93
61. Akbari O, Stock P, Meyer E, Kronenberg M, Sidobre S, et al. 2003. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 9:582-88
62. Lisbonne M, Diem S, de Castro Keller A, Lefort J, Araujo LM, et al. 2003. Cutting edge: Invariant Vα14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J. Immunol. 171:1637-41
63. Mempel M, Ronet C, Suarez F, Gilleron M, Puzo G, et al. 2002. Natural killer T cells restricted by the monomorphic MHC class 1bCD1d1 molecules behave like inflammatory cells. J. Immunol. 168:365-71
64. i NKT cells. Nat. Immunol 3:966-74
65. Ranson T, Vosshenrich CA, Corcuff E, Richard O, Laloux V, et al. 2003. IL-15 availability conditions homeostasis of peripheral natural killer T cells. Proc. Natl. Acad. Sci. USA 100:2663-68
66. + NKT cells in germ-free mice. Eur. J. Immunol. 30:620-25
67. + NKT lymphocytes are activated memory cells. Eur. J. Immunol. 30:1544-50
68. - NKT cells with distinct TCR αβ repertoires and differential distribution in lymphoid tissues. J. Immunol. 165:2481-90
69. + NK T cells. J. Immunol. 166:1755-62
70. Matsuda JL, Gapin L, Fazilleau N, Warren K, Naidenko OV, Kronenberg M. 2001. Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor β repertoire and small clone size. Proc. Natl. Acad. Sci. USA 98:12636-41
71. Eberl G, MacDonald HR. 1998. Rapid death and regeneration of NKT cells in anti-CD3ε- or IL-12-treated mice: a major role for bone marrow in NKT cell homeostasis. Immunity 9:345-53
72. Osman Y, Kawamura T, Naito T, Takeda K, Van Kaer L, et al. 2000. Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide. Eur. J. Immunol. 30:1919-28
73. Leite-de-Moraes MC, Herbelin A, Gouarin C, Koezuka Y, Schneider E, Dy M. 2000. Fas/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes. J. Immunol. 165:4367-71
74. Hayakawa Y, Takeda K, Yagita H, Kakuta S, Iwakura Y, et al. 2001. Critical contribution of IFN-γ and NK cells, but not perforin-mediated cytotoxicity, to antimetastatic effect of α-galactosylceramide. Eur. J. Immunol. 31:1720-27
75. Nakagawa R, Nagafune I, Tazunoki Y, Ehara H, Tomura H, et al. 2001. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by α-galactosylceramide in mice. J. Immunol. 166:6578-84
76. Wilson MT, Johansson C, Olivares-Villagomez D, Singh AK, Stanic AK, et al. 2003. The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc. Natl. Acad. Sci. USA 100:10913-18
77. Crowe NY, Uldrich AP, Kyparissoudis K, Hammond KJ, Hayakawa Y, et al. 2003. Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells. J. Immunol. 171:4020-27
78. Harada M, Seino K, Wakao H, Sakata S, Ishizuka Y, et al. 2004. Down-regulation of the invariant Vα14 antigen receptor in NKT cells upon activation. Int. Immunol. 16:241-47
79. Burdin N, Brossay L, Kronenberg M. 1999. Immunization with α-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur. J. Immunol. 29:2014-25
80. Singh N, Hong S, Scherer DC, Serizawa I, Burdin N, et al. 1999. Cutting edge: Activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J. Immunol. 163:2373-77
81. Cui J, Watanabe N, Kawano T, Yamashita M, Kamata T, et al. 1999. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Vα14 natural killer T cells. J. Exp. Med. 190:783-92
82. Gumperz JE, Roy C, Makowska A, Lum D, Sugita M, et al. 2000. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12:211-21
83. Rauch J, Gumperz J, Robinson C, Skold M, Roy C, et al. 2003. Structural features of the acyl chain determine self-phospholipid antigen recognition by a CD1d-restricted invariant NKT (iNKT) cell. J. Biol. Chem. 278:47508-15
84. + T lymphocytes. J. Immunol. 168:5514-20
85. Gui M, Li J, Wen LJ, Hardy RR, Hayakawa K. 2001. TCRβ chain influences but does not solely control autore-activity of Vα14J281 T cells. J. Immunol. 167:6239-46
86. Wu DY, Segal NH, Sidobre S, Kronenberg M, Chapman PB. 2003. Cross-presentation of disialoganglioside GD3 to natural killer T cells. J. Exp. Med. 198:173-81
87. Fischer K, Scotet E, Niemeyer M, Koebernick H, Zerrahn J, et al. 2004. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc. Natl. Acad. Sci. USA 101:10685-90
88. Gadola SD, Zaccai NR, Harlos K, Shepherd D, Castro-Palomino JC, et al. 2002. Structure of human CD1b with bound ligands at 2.3 Å, a maze for alkyl chains. Nat. Immunol. 3:721-26
89. Zajonc DM, Elsliger MA, Teyton L, Wilson IA. 2003. Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 Å. Nat. Immunol. 4:808-15
90. Batuwangala T, Shepherd D, Gadola SD, Gibson KJ, Zaccai NR, et al. 2004. The crystal structure of human CD1b with a bound bacterial glycolipid. J. Immunol. 172:2382-88
91. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, et al. 1997. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 278:1626-29
92. Brossay L, Naidenko O, Burdin N, Matsuda J, Sakai T, Kronenberg M. 1998. Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells. J. Immunol. 161:5124-28
93. Prigozy TI, Naidenko O, Qasba P, Elewaut D, Brossay L, et al. 2001. Glycolipid antigen processing for presentation by CD1d molecules. Science 291:664-67
94. Sidobre S, Naidenko OV, Sim BC, Gascoigne NR, Garcia KC, Kronenberg M. 2002. The Vα14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex. J. Immunol. 169:1340-48
95. Sim BC, Holmberg K, Sidobre S, Naidenko O, Niederberger N, et al. 2003. Surprisingly minor influence of TRAV11 (Vα14) polymorphism on NK T-receptor mCD1/α-galactosylceramide binding kinetics. Immunogenetics 54:874-83
96. Cantu C III, Benlagha K, Savage PB, Bendelac A, Teyton L. 2003. The paradox of immune molecular recognition of α-galactosylceramide: low affinity, low specificity for CD1d, high affinity for αβ TCRs. J. Immunol. 170:4673-82
97. i NKT cells has a unique mode of glycosphingolipid antigen recognition. Proc. Natl. Acad. Sci. USA 101:12254-59
98. Leite-De-Moraes MC, Hameg A, Arnould A, Machavoine F, Koezuka Y, et al. 1999. A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement. J. Immunol. 163:5871-76
99. Leite-De-Moraes MC, Moreau G, Arnould A, Machavoine F, Garcia C, et al. 1998. IL-4-producing NK T cells are biased towards IFN-γ production by IL-12. Influence of the microenvironment on the functional capacities of NK T cells. Eur. J. Immunol. 28:1507-15
100. Brigl M, Bry L, Kent SC, Gumperz JE, Brenner MB. 2003. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4:1230-37
101. Chiu YH, Jayawardena J, Weiss A, Lee D, Park SH, et al. 1999. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J. Exp. Med. 189:103-10
102. Ikarashi Y, Mikami R, Bendelac A, Terme M, Chaput N, et al. 2001. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon γ production. J. Exp. Med. 194:1179-86
103. Moody DB, Young DC, Cheng TY, Rosat JP, Roura-Mir C, et al. 2004. T cell activation by lipopeptide antigens. Science 303:527-31
104. Metelitsa LS, Naidenko OV, Kant A, Wu HW, Loza MJ, et al. 2001. Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells. J. Immunol. 167:3114-22
105. Miyamoto K, Miyake S, Yarnamura T. 2001. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413:531-34
106. Stanic AK, Shashidharamurthy R, Bezbradica JS, Matsuki N, Yoshimura Y, et al. 2003. Another view of T cell antigen recognition: cooperative engagement of glycolipid antigens by Vα14Jα 18 natural T (iNKT) cell receptor. J. Immunol. 171:4539-51. Erratum. 2004. J. Immunol. 172:717
107. Stanic AK, Shashidharamurthy R, Bezbradica JS, Matsuki N, Yoshimura Y, et al. 2003. Another view of T cell antigen recognition: cooperative engagement of glycolipid antigens by Vα14Jα 18 natural T (iNKT) cell receptor. J. Immunol. 171:4539-51. Erratum. 2004. J. Immunol. 172:717
108. Oki S, Chiba A, Yamamura T, Miyake S. 2004. The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells. J. Clin. Invest. 113:1631-40
109. Schmieg J, Yang G, Franck RW, Tsuji M. 2003. Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand α-galactosylceramide. J. Exp. Med. 198:1631-41
110. i natural killer T cells are resistant to cytokine polarization in vivo. Proc. Natl. Acad. Sci. USA 100:8395-400
111. Carnaud C, Lee D, Donnars O, Park SH, Beavis A, et al. 1999. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163:4647-50
112. Eberl G, MacDonald HR. 2000. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur. J. Immunol. 30:985-92
113. + T cells upon NKR-P1 cross-linking. J. Exp. Med. 183:2391-96
114. Fujii S, Shimizu K, Kronenberg M, Steinman RM. 2002. Prolonged IFN-γ-producing NKT response induced with α-galactosylceramide- loaded DCs. Nat. Immunol. 3:867-74
115. Vincent MS, Leslie DS, Gumperz JE, Xiong X, Grant EP, Brenner MB. 2002. CD1-dependent dendritic cell instruction. Nat Immunol. 3:1163-68
116. + T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J. Immunol. 171:5140-47
117. Fujii S, Shimizu K, Smith C, Bonifaz L, Steinman RM. 2003. Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 198:267-79
118. Chung Y, Chang WS, Kim S, Kang CY. 2004. NKT cell ligand α-galactosylceramide blocks the induction of oral tolerance by triggering dendritic cell maturation. Eur. J. Immunol. 34:2471-79
119. Kitamura H, Ohta A, Sekimoto M, Sato M, Iwakabe K, et al. 2000. α-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells. Cell. Immunol. 199:37-42
120. Galli G, Nuti S, Tavarini S, Galli-Stampino L, De Lalla C, et al. 2003. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. J. Exp. Med. 197:1051-57
121. + T cells in vivo. J. Immunol. 170:2540-48
122. Nishimura T, Kitamura H, Iwakabe K, Yahata T, Ohta A, et al. 2000. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int. Immunol. 12:987-94
123. Gonzalez-Aseguinolaza G, Van Kaer L, Bergmann CC, Wilson JM, Schmieg J, et al. 2002. Natural killer T cell ligand α-galactosylceramide enhances protective immunity induced by malaria vaccines. J. Exp. Med. 195:617-24
124. Kitamura H, Iwakabe K, Yahata T, Nishimura S, Ohta A, et al. 1999. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189:1121-28
125. +NKT cells: Stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J. Immunol. 163:93-101
126. + T cells responding to serologically defined autoantigens suppress antitumor immune responses. Proc. Natl. Acad. Sci. USA 100:10902-6
127. + regulatory T cells suppress NKT cell functions. Cancer Res. 63:4516-20
128. Hansen DS, Siomos MA, Buckingham L, Scalzo AA, Schofield L. 2003. Regulation of murine cerebral malaria pathogenesis by CD1d-restricted NKT cells and the natural killer complex. Immunity 18:391-402
129. Crowe NY, Smyth MJ, Godfrey DI. 2002. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas. J. Exp. Med. 196:119-27
130. Gillessen S, Naumov YN, Nieuwenhuis EE, Exley MA, Lee FS, et al. 2003. CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion. Proc. Natl. Acad. Sci. USA 100:8874-79
131. Fuss IJ, Heller F, Boirivant M, Leon F, Yoshida M, et al. 2004. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J. Clin. Invest. 113:1490-97
132. Exley MA, Bigley NJ, Cheng O, Tahir SM, Smiley ST, et al. 2001. CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus. J. Leukoc. Biol. 69:713-18
133. Baron JL, Gardiner L, Nishimura S, Shinkai K, Locksley R, Ganem D. 2002. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 16:583-94
134. Durante-Mangoni E, Wang R, Shaulov A, He Q, Nasser I, et al. 2004. Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells. J. Immunol. 173:2159-66
135. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med. 187:1047-56
136. Singh AK, Wilson MT, Hong S, Olivares-Villagomez D, Du C, et al. 2001. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 194:1801-11
137. Sonoda KH, Faunce DE, Taniguchi M, Exley M, Balk S, Stein-Streilein J. 2001. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J. Immunol. 166:42-50
138. Beaudoin L, Laloux V, Novak J, Lucas B, Lehuen A. 2002. NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic β cells. Immunity 17:725-36
139. + T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide. Blood 99:1259-66
140. Heller F, Fuss IJ, Nieuwenhuis EE, Blumberg RS, Strober W. 2002. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 17:629-38
141. Ito K, Karasawa M, Kawano T, Akasaka T, Koseki H, et al. 2000. Involvement of decidual Vα14 NKT cells in abortion. Proc. Natl. Acad. Sci. USA 97:740-44
142. Tupin E, Nicoletti A, Elhage R, Rudling M, Ljunggren HG, et al. 2004. CD1d-dependent activation of NKT cells aggravates atherosclerosis. J. Exp. Med. 199:417-22
143. Nakai Y, Iwabuchi K, Fujii S, Ishimori N, Dashtsoodol N, et al. 2004. Natural killer T cells accelerate atherogenesis in mice. Blood 104:2051-59
144. + NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin. Immunol. 100:144-48
145. Wilson SB, Kent SC, Patton KT, Orban T, Jackson RA, et al. 1998. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes. Nature 391:177-81
146. Kukreja A, Cost G, Marker J, Zhang C, Sun Z, et al. 2002. Multiple immunoregulatory defects in type-1 diabetes. J. Clin. Invest. 109:131-40
147. Berzins SP, Kyparissoudis K, Pellicci DG, Hammond KJ, Sidobre S, et al. 2004. Systemic NKT cell deficiency in NOD mice is not detected in peripheral blood: implications for human studies. Immunol. Cell. Biol. 82:247-52
148. Tahir SM, Cheng O, Shaulov A, Koezuka Y, Bubley GJ, et al. 2001. Loss of IFN-γ production by invariant NK T cells in advanced cancer. J. Immunol. 167:4046-50
149. + NKT cells derived from multiple sclerosis in remission. Int. Immunol. 15:279-88
150. Levy O, Orange JS, Hibberd P, Steinberg S, LaRussa P, et al. 2003. Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells. J. Infect. Dis. 188:948-53
151. + NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood 103:383-89
152. Giaccone G, Punt CJ, Ando Y, Ruijter R, Nishi N, et al. 2002. A phase I study of the natural killer T-cell ligand α-galactosylceramide (KRN7000) in patients with solid tumors. Clin. Cancer Res. 8:3702-9
153. Zhou D, Mattner J, Cantu Iii C, Schrantz N, Yin N, et al. 2004. Lysosomal glycosphingolipid recognition by NKT cells. Science 306:1786-89